icon-folder.gif   Conference Reports for NATAP  
 
  The International Liver Congress™
EASL 2017 - European Association for the
Study of the Liver
Amsterdam, The Netherlands. 2017
Back grey_arrow_rt.gif
 
 
 
Real-world effectiveness and cost per SVR of
Sofosbuvir/Velpatasvir in chronic hepatitis C treatment / GT3

 
 
  Reported by Jules Levin
EASL 2017 April 19-23 Amsterdam Netherlands
 
Peter Buggisch1, Petar Atanasov2, Karsten Wursthorn1, Albrecht Stoehr1, Jorg Petersen1 1Asklepios Klinik St. Georg, IFI Institut fur Interdisziplinäre Medizin, Hamburg, Germany 2Amaris, London, United Kingdom

0426171

0426172

0426173

0426174

0426175